Real-World Analysis of Treatment Patterns and Platinum-Based Treatment Eligibility of Patients With Metastatic Urothelial Cancer in 5 European Countries-Reference-Cited by-同舟云学术

Real-World Analysis of Treatment Patterns and Platinum-Based Treatment Eligibility of Patients With Metastatic Urothelial Cancer in 5 European Countries

Published:2023-10 Issue: Volume: Page:
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Milloy Neil,Kirker Melissa,Unsworth Mia,Montgomery Rachel,Kluth Caspian^ORCID,Kearney Mairead,Chang Jane

Funder

Pfizer Global Pharmaceuticals

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference27 articles.

1. Epidemiology of bladder cancer;Saginala;Med Sci (Basel),2020

2. Bladder cancer;Kaseb,2023

3. The challenge of managing bladder cancer and upper tract urothelial carcinoma: A review with treatment recommendations from the Spanish oncology genitourinary group (SOGUG);Font;Target Oncol,2019

4. Treatment of metastatic urothelial cancer of the bladder and urinary tract. UpToDate;Bellmunt,2022

5. Impact of bladder cancer on health-related quality of life;Smith;BJU Int,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma;The Oncologist;2024-08-21

2. A Podcast on Practical Considerations in Patients with Advanced Urothelial Cancer Receiving First-Line Cisplatin- or Carboplatin-Based Chemotherapy Followed by Avelumab Maintenance in a Changing Therapeutic Landscape;Advances in Therapy;2024-07-18

3. Understanding Clinician Preferences for Treatment Attributes in Oncology: A Discrete Choice Experiment of Oncologists’ and Urologists’ Preferences for First-Line Treatment of Locally Advanced/Unresectable Metastatic Urothelial Carcinoma in Five European Countries;PharmacoEconomics;2024-03-12